0.0007
0.0002 (40.0%)
0.0002 (40.0%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Small Cap Basic
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| PharmaRoth Labs Inc (CE) | ROTH | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0002 | 40.0% | 0.0007 | 15:56:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0008 | 0.0006 | 0.0008 | 0.0007 | 0.0005 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.0005 | 0.0005 | 0.00 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6 | 489,472 | $ 0.000767 | $ 375 | - | 0.000001 - 0.0052 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:56:57 | 206,250 | $ 0.0007 | USD |
PharmaRoth Labs (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 245.83k | 351.18M | 200.12M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 26.50k | $ - | 0.00% | - | - |
PharmaRoth Labs (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ROTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0008 | 0.0008 | 0.0004 | 0.0007694 | 128,625 | -0.0001 | -12.5% |
| 1 Month | 0.0007 | 0.001 | 0.000001 | 0.0006244 | 217,177 | 0.00 | 0.0% |
| 3 Months | 0.001 | 0.001 | 0.000001 | 0.0004808 | 199,678 | -0.0003 | -30.0% |
| 6 Months | 0.0014 | 0.0016 | 0.000001 | 0.0006256 | 231,780 | -0.0007 | -50.0% |
| 1 Year | 0.0006 | 0.0052 | 0.000001 | 0.0024174 | 1,459,205 | 0.0001 | 16.67% |
| 3 Years | 0.00345 | 0.0052 | 0.000001 | 0.0022139 | 973,016 | -0.00275 | -79.71% |
| 5 Years | 0.0065 | 0.014 | 0.000001 | 0.0026572 | 709,823 | -0.0058 | -89.23% |
PharmaRoth Labs (CE) Description
| PharmaRoth Labs, Inc. is focused on diabetes prevention and treatments. The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon(R), an oral treatment for Type-II diabetes. Sucanon(R) is a member of a class of diabetic medications called insulin sensitizers. Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver's sensitivity to insulin. Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars. PharmaRoth's strategy is to increase awareness, acceptance, and distribution of Sucanon(R) globally. |
